Executive team

Agustin Fernandez


Chief Executive Officer

Olivier Jarry


Chief Financial Officer

Kerstin Westritschnig, MD


Chief Medical Officer

David Brindley, DPhil, MEng; PG Cert, (IP), RAC (US), FRSA, FRSB


Chief Regulatory & IP Officer

Edward Gershburg, PhD


Chief Technology Officer

Rodolfo Dominguez


Chief of Staff

Konstantin Kousoulas PhD


VP of Scientific Affairs

Gerhard Hager, PhD


Head of Non-Clinical Development

Christy Mazzarisi


Global Quality Officer

Brandie Murphy


Lab Manager

Quinn Steele


Head of GxP and Regulatory E-Systems

Diane Abbitt, Esq


Patient Advocate

Scientific Advisory Board

Paul Predki, PhD


SAB Chair, Biotech executive, co-founder and CTO of Iridia Inc.

Rahul Singhvi, ScD, MBA


Operating Partner, Flagship Pioneering

Lional Raj, MD


Medical Director, Department of Cornea and Refractive Surgery, Dr. Agarwal’s Eye Hospital, India

Georg Holländer, MA, MD, FMedSci, FRCPCH, FHM Pediatrics


Chair, Department of Pediatrics, University of Oxford, Oxford, UK

Maria Hamdy El Sayed, MBBCh,MSc ,M.D


SAB Chair, Professor of Dermatology at Ain Shams University

Todd Margolis, MD, PhD


Chair, Department of Ophthalmology, Washington University, St. Louis, MO, USA

Jim Robinson, BS, MS


Industry Consultant

David I. Bernstein, MD, MA


Professor of Pediatric Infectious Diseases at Cincinnati Children’s Hospital Medical Center

Stanley A. Plotkin, MD


Emeritus Professor at the University of Pennsylvania

Alan Kimura, MD, PhD


SVP & Therapeutic Area Head for Rare Diseases at CureVac

Clinical Advisory Board

Luis Rios-Nogales, MD, PhD, MBA


Chair

Rajul Patel, MRCP(UK), FRCP, CCT in Genitourinary Medicine


Member